Clinical TrialID 8187

Cytisine for Smoking Cessation

NCT05729243

Tobacco Use Disorder|Alcohol Use Disorder|Smoking Cessation

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8187
Evidence Id
8187
Core Evidence Id
8187
Source Clinical Trial Id
8185
Herb2 Clinical Trial Id
HBCT008185
Nct Id
NCT05729243
Title
Cytisine for Smoking Cessation
Status
Recruiting
Phase
Phase 4
Study Result
No
Study Condition
Tobacco Use Disorder|Alcohol Use Disorder|Smoking Cessation
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Cytisine|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
48
Outcome Measure
Frequency and type of adverse events, To assess the tolerability of cytisine, Total duration of trial (24 weeks)|Rate of retention in the trial: number of sessions completed for each participant and number ofparticipants who withdraw, To assess the tolerability of cytisine, Total duration of trial (24 weeks)
Sponsor Collaborator
Centre for Addiction and Mental Health
Funded By
OTHER
Location
Center for Addiction and Mental Health, Toronto, Ontario, M5S 2S1, Canada
Other Id
054-2022
Start Date
2023-02-08
Primary Completion Date
2024-01
Completion Date
2024-06
First Posted
2023-02-15
Results First Posted
Last Update Posted
2023-04-06
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05729243
Title Cn
Title En
Cytisine for Smoking Cessation
Bilingual Status
semi_complete